Five@slrpnk.net to World News@beehaw.orgEnglish · 6 months agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square34fedilinkarrow-up1224arrow-down10cross-posted to: piracy@lemmy.dbzer0.com
arrow-up1224arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comFive@slrpnk.net to World News@beehaw.orgEnglish · 6 months agomessage-square34fedilinkcross-posted to: piracy@lemmy.dbzer0.com
minus-squareGenEcon@lemm.eelinkfedilinkarrow-up5·6 months agoYou can look it up: https://www.novonordisk.com/partnering-and-open-innovation/open-innovation/private-public-partnerships.html
minus-squareunderisk@lemmy.mllinkfedilinkarrow-up8·edit-26 months agonothing on this page mentions anything about Ozempic, semaglutide, or the amounts of funding received. the closest thing is a list of current diabetes research projects with, again, no amounts listed and no clear relation to ozempic.
You can look it up: https://www.novonordisk.com/partnering-and-open-innovation/open-innovation/private-public-partnerships.html
nothing on this page mentions anything about Ozempic, semaglutide, or the amounts of funding received. the closest thing is a list of current diabetes research projects with, again, no amounts listed and no clear relation to ozempic.
deleted by creator